chr16-4797755-A-G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM1BP4_Strong
The NM_024589.3(ROGDI):c.781T>C(p.Phe261Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000334 in 1,557,322 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. F261F) has been classified as Likely benign.
Frequency
Consequence
NM_024589.3 missense
Scores
Clinical Significance
Conservation
Publications
- amelocerebrohypohidrotic syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_024589.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ROGDI | NM_024589.3 | MANE Select | c.781T>C | p.Phe261Leu | missense | Exon 10 of 11 | NP_078865.1 | ||
| ROGDI | NR_046480.2 | n.788T>C | non_coding_transcript_exon | Exon 9 of 10 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ROGDI | ENST00000322048.12 | TSL:1 MANE Select | c.781T>C | p.Phe261Leu | missense | Exon 10 of 11 | ENSP00000322832.6 | ||
| ROGDI | ENST00000591392.5 | TSL:3 | c.709T>C | p.Phe237Leu | missense | Exon 9 of 9 | ENSP00000467509.1 | ||
| ROGDI | ENST00000586504.5 | TSL:5 | c.509T>C | p.Leu170Pro | missense | Exon 6 of 7 | ENSP00000465076.1 |
Frequencies
GnomAD3 genomes AF: 0.000142 AC: 17AN: 120100Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000517 AC: 13AN: 251256 AF XY: 0.0000515 show subpopulations
GnomAD4 exome AF: 0.0000244 AC: 35AN: 1437136Hom.: 0 Cov.: 37 AF XY: 0.0000308 AC XY: 22AN XY: 714796 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000141 AC: 17AN: 120186Hom.: 0 Cov.: 32 AF XY: 0.000119 AC XY: 7AN XY: 58638 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.781T>C (p.F261L) alteration is located in exon 10 (coding exon 10) of the ROGDI gene. This alteration results from a T to C substitution at nucleotide position 781, causing the phenylalanine (F) at amino acid position 261 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Amelocerebrohypohidrotic syndrome Uncertain:1
This sequence change replaces phenylalanine with leucine at codon 261 of the ROGDI protein (p.Phe261Leu). The phenylalanine residue is moderately conserved and there is a small physicochemical difference between phenylalanine and leucine. This variant is present in population databases (rs371511979, ExAC 0.04%). This variant has not been reported in the literature in individuals affected with ROGDI-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at